Researchers in Hungary conducted a study of kidney transplant recipients and found that 25 percent had moderate to severe sleep apnea, a rate similar to that seen
in kidney disease patients on dialysis awaiting a transplant.
As a result, even though the sense of smell has a major contribution to the flavors of foods, most efforts to increase food intake
in kidney disease patients have focused on the sense of taste and direct appetite stimulation.
Not exact matches
TRENTON, N.J. — The U.S. Food and Drug Administration has approved the first drug to slow
kidney decline
in patients with the most common inherited
kidney disease.
Study Suggests a Little Wine May be Good for Your
Kidneys: Moderate wine consumption could help keep the kidneys healthy, and may protect the heart in patients who already have kidney disease, according to new find
Kidneys: Moderate wine consumption could help keep the
kidneys healthy, and may protect the heart in patients who already have kidney disease, according to new find
kidneys healthy, and may protect the heart
in patients who already have
kidney disease, according to new findings...
He has published seminal works on blood pressure management through his role
in the BPLTTC and played leading roles
in a series of trials that define the clinical management of
patients with diabetes and chronic
kidney disease.
DeepMind announced
in February that it was working with the NHS, saying it was building an app called Streams to help hospital staff monitor
patients with
kidney disease.
Sleep apnea may accelerate
kidney function decline in diabetic patients with kidney disease, according to a study that will be presented at ASN Kidney Week 2014 November 11 - 16 at the Pennsylvania Convention Center in Philadelphia
kidney function decline
in diabetic
patients with
kidney disease, according to a study that will be presented at ASN Kidney Week 2014 November 11 - 16 at the Pennsylvania Convention Center in Philadelphia
kidney disease, according to a study that will be presented at ASN
Kidney Week 2014 November 11 - 16 at the Pennsylvania Convention Center in Philadelphia
Kidney Week 2014 November 11 - 16 at the Pennsylvania Convention Center
in Philadelphia, PA..
Led by Stella K. Kang, a radiologist with the Department of Radiology at the New York School of Medicine, the study was designed to compare the effectiveness of a treatment algorithm for small renal tumors incorporating the nephrometry score, a renal tumor anatomy scoring system developed by urologists, with the current standard of uniformly recommended partial nephrectomy
in patients with mild - to - moderate chronic
kidney disease (CKD).
A recently - developed mobile phone application could make monitoring conditions such as diabetes,
kidney disease, and urinary tract infections much clearer and easier for both
patients and doctors, and could eventually be used to slow or limit the spread of pandemics
in the developing world.
Lifestyle and dietary modifications to maintain vascular health or reduce
disease risk might help protect
patients» heart health, but there are currently limited diet - based therapeutic approaches to counteract cardiovascular
disease in patients with
kidney failure.
More than 90 per cent of educational materials written for
kidney disease patients is higher than an average patient's literacy, according to a new study published in the June issue of the National Kidney Foundation's American Journal of Kidney Dis
kidney disease patients is higher than an average
patient's literacy, according to a new study published
in the June issue of the National
Kidney Foundation's American Journal of Kidney Dis
Kidney Foundation's American Journal of
Kidney Dis
Kidney Diseases.
«Sepsis is the leading cause of death
in intensive care units
in the United States, and
patients with the diagnosis of sepsis have a minimum of a 30 percent chance of dying of their
disease; if their vital organ systems — brain, heart, lungs, liver,
kidneys — are affected, they have a 70 percent chance of dying.
«Diet and exercise can improve
kidney function
in patients with fatty liver
disease.»
Importantly,
in patients whose liver
disease improved, there was also an improvement
in kidney function even after several adjustments by potential confounding factors such as diabetes, hypertension, concurrent medications and weight loss by itself.
Although nanobacteria may not cause
kidney stone
disease, Coe notes additional circumstantial evidence: At least four teams have reported tiny spherical deposits
in the calcified plaques that often appear
in the
kidneys of
patients who suffer from
kidney stones.
A new study published
in the Journal of the American Medical Association found depressed
patients with chronic
kidney disease did not benefit from a common antidepressant.
Medicare spending for
patients with chronic
kidney disease aged 65 and older exceeded $ 50 billion
in 2013 and represented 20 percent of all Medicare spending
in that age group.
«We have the same tools
in our arsenal to help these
patients in terms of their progression of
kidney disease; so our research raises questions and challenges the field of physicians,» says Thakar.
A Massachusetts General Hospital (MGH) study has found that deficits
in the sense of smell are important contributors to the frequently observed lack of appetite
in patients with serious
kidney disease.
Patients with multiple illnesses such as heart
disease,
kidney disease and dementia, and rural residency were less likely than others to receive follow - up care
in the following month.
«The majority of
patients with chronic
kidney disease, particularly those
in the more advanced stages who require dialysis, exhibited some degree of loss of their sense of smell, which correlated with reduced nutritional status,» says Teodor Paunescu, PhD, of the MGH Division of Nephrology, corresponding author of the study.
In patients with chronic
kidney disease who are not on dialysis, ACEIs and ARBs slow the progression of diabetic nephropathy and reduce cardiovascular risk.
Rheumatoid arthritis
patients are likelier than the average person to develop chronic
kidney disease, and more severe inflammation
in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the risk factors, new Mayo Clinic research shows.
«These medications are often stopped when
patients are
in the late, but pre-dialysis, stages of
kidney disease because of the risk of dangerously high potassium levels.
To reduce their risk of developing
kidney disease,
patients should be attentive to their blood pressure and keep it under control, maintain a diet that isn't high
in salt; avoid or reduce use of medications that are directly toxic to the
kidneys; including nonsteroidal anti-inflammatory drugs; and get their rheumatoid arthritis and inflammation under as good of control as possible, he adds.
Kidney disease patients often lose their interest
in food, reporting that it has little flavor or an unpleasant taste, and the malnutrition that results is a significant contributor to worsening of symptoms and mortality risk.
In the longer term, these methods could hasten progress toward replacing a damaged or
diseased kidney with tissue derived from a
patient's own cells.
Chronic
kidney disease stage 2 or more was present
in one third of
patients.
Plasma levels of this biomarker rose with
kidney deterioration
in patients with MMA, and may serve as a valuable indicator of MMA
kidney disease progression
in the clinic.
In the early 1980s, a team in France found that dialysis patients with advanced kidney disease had fewer cardiovascular complications and longer survival times if they were overweigh
In the early 1980s, a team
in France found that dialysis patients with advanced kidney disease had fewer cardiovascular complications and longer survival times if they were overweigh
in France found that dialysis
patients with advanced
kidney disease had fewer cardiovascular complications and longer survival times if they were overweight.
Certain linear GBCAs have previously been linked to a rare but serious
disease (called nephrogenic systemic fibrosis)
in patients with severely impaired
kidney function.
In 2015, 87,538
patients with end - stage renal
disease died while on dialysis (16.3 percent of all dialysis
patients are awaiting
kidney transplants), and 18,805
kidney transplantations were performed that same year.
Editorial: Warfarin Treatment
in Patients With Atrial Fibrillation and Advanced Chronic
Kidney Disease
Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among
patients with chronic
kidney disease would increase the risk of death or stroke, a study that included more than 24,000
patients found a lower l - year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study
in the March 5 issue of JAMA.
Because individuals with
kidney dysfunction must maintain diets low
in phosphorus and potassium, it's unclear if sodium - reduced foods are safe for
patients with
kidney disease.
«Also whether sickle trait is more common
in dialysis
patients because it contributes to
kidney disease should be explored further
in future research.»
«
Patients with chronic
kidney disease need to be aware of the potential for higher potassium content
in sodium - reduced foods, as they are educated to follow a low sodium diet and may inadvertently choose sodium - reduced foods without realizing the risk of an increased potassium load from additives,» she said.
They also must take drugs to treat anemia, which commonly arises
in patients with
kidney disease because healthy
kidneys are needed to generate the hormone that stimulates red blood cell production.
Patients with levels above 3000 picogram per milliliter carry a much higher risk for
kidney disease in the general population.
For this study, the researchers used data from a population of
patients with both diabetes and chronic
kidney disease (stage 3 and 4) enrolled
in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 15 years.
This new test could help doctors assess
disease risk
in their
patients and guide researchers to develop more effective therapies to prevent or treat
kidney failure.
Hypertension is the most important treatable risk factor for cardiovascular
disease, and while it is especially common
in the elderly and
in patients with chronic
kidney disease (CKD), these are the least studied groups
in randomized controlled trials examining the health effects of lowering blood pressure.
The researchers» analysis included 22 pregnancies
in the Toronto Pregnancy and
Kidney Disease Clinic and Registry (2000 - 2013) with 70 pregnancies
in the American Registry for Pregnancy
in Dialysis
Patients (1990 - 2011).
To investigate, Csaba Kovesdy, MD (Memphis VA Medical Center and the University of Tennessee Health Science Center) and his colleagues examined information from the national VA research database and looked for associations between blood pressure and various clinical outcomes — coronary heart
disease, stroke,
kidney failure, and death —
in more than 300,000
patients with CKD.
• Systolic blood pressure levels above 140 mmHg were linked with higher risks of coronary heart
disease, stroke,
kidney failure, and death
in patients with CKD of all ages, but the magnitude of these associations diminished with more advanced age.
Joachim Fandrey, a physiologist at the University of Duisburg - Essen
in Germany, adds that the results suggest that nitroglycerin patches, which have a long track record
in treating chest pain
in heart
disease patients, might boost EPO production
in people suffering from anemia due to
kidney disease or cancer.
Based on this review, they suggest a «probable» association between vitamin D levels and birth weight, dental caries
in children, maternal vitamin D levels at term and parathyroid hormone levels
in chronic
kidney disease patients requiring dialysis, but «further studies and better designed trials are needed to draw further conclusions.»
In a
patient with chronic
kidney disease, the extent of their renal fibrosis usually predicts progression to end - stage
kidney disease.
But these issues are mitigated by HCV antiviral therapy, specifically pegylated interferon plus ribavirin, which was found to reduce risks of
kidney disease, stroke and cardiovascular
diseases in diabetic
patients,» concludes Dr. Wu.
Of the 1,000
patients included
in this analysis, 60 percent were male and the average age was 61; 49 percent had cardiac
disease, 41 percent diabetes, 30 percent chronic
kidney disease and 17 percent sleep apnea.